Adam Scott Levy, Chief Business Officer at MIRAGEN THERAPEUTICS, INC. (MGEN), bought 9,090 shares at $5.50 ($50K) on 2018-02-13, disclosed to the SEC on 2018-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MLYS | SELL | 2025-10-15 | $904K | — | Filing → |
| MLYS | SELL | 2025-07-30 | $1.4M | — | Filing → |
| MLYS | SELL | 2025-07-15 | $311K | — | Filing → |